Hapacol Sủi

Analgesic antipyretic, effervescent tablets
Barcode: 8935206094749


Paracetamol...................................... 500 mg

Excipients.q.s................................... 1 tablet

(Tartaric acid, anhydrous citric acid, aspartame, anhydrous lactose, sunnet sugar, sodium hydrocarbonate, ludipress LCE, effersoda, sodium benzoate, PEG 6000, orange-flavored powder, talc, PVP K30).

DOSAGE FORM: Effervescent tablets.

PRESENTATION:     Box of 4 blisters x 4 effervescent tablets.      Box of 10 blisters x 4 effervescent tablets.

ACTIONS: Paracetamol is effectively analgesic, antipyretic. Paracetamol has action on the hypothalamic heat-regulating center causing hypothermia, increase in thermolysis due to vasodilation and peripheral hypervolemia; this relieves the body temperature in fever patients, but rarely in the normal body. Paracetamol produces analgesia by elevation of the pain threshold.

Paracetamol is rapidly and completely absorbed by the gastrointestinal tract. The elimination half-life of paracetamol varies from about 1.25 to 3 hours. Paracetamol is metabolized predominantly by the liver and excreted by the kidney.

Hapacol contains 500 mg of paracetamol, is prepared in the dosage form of effervescent tablets, is dissolved in water before oral administration; therefore, it is suitable for patients meeting difficulty in taking pills. The drug is dissolved in water before oral administration, so it is easily absorbed by the digestive system and quickly brings into play its effect to attain a high effectiveness.

INDICATIONS: Treatment of painful symptoms in cases of headache, migraine, toothache, aches and pains caused by flu, sore throat, musculoskeletal pains, arthritis-induced pains, pains after vaccination or tooth extraction.

Antipyretic actions on patients with cold or diseases associated with fever.

CONTRAINDICATIONS: Hypersensitivity to paracetamol. Patients with anemia, cardiopathy, pneumopathy, renopathy.

In case of glucose - 6 - phosphate dehydrogenase deficiency; impaired hepatic function.

PRECAUTIONS: Paracetamol may cause liver damage if you consume more alcoholic drinks; it is advised to avoid or reduce alcohol consumption.

Patients on low-sodium or sodium-free diets are warned that the drug contains sodium salt.

INTERACTIONS: Long-term use of high-dose Paracetamol mildly increases the anticoagulant effect of coumarin and indandion derivative.

A serious antipyretic effect may be reported in patients co-administered phenothiazine and hypothermic therapy.

Anticonvulsants (phenytoin, barbiturate, carbamazepin) may cause hepatic microsomal enzyme induction, probably increasing the hepatotoxicity of Paracetamol because of accelerated metabolism to substances harmful to the liver.

Concurrent use of isoniazide and Paracetamol may show to increase risk of hepatotoxicity.

ADVERSE EFFECTS: Uncommonly: Skin: skin rash.

Gastrointestinal tract: nausea, vomiting.

Hematology: neutrophilopenia, hypoleukemia, anemia.

Kidney: renopathy, rephrotoxicity due to prolonged abuse.

Rarely: hypersensitive reactions.

Prolonged and high-dose use of Hapacol shows to cause hepatic impairment (due to hepatolysis).

Inform your physician about any adverse effects occur during the treatment.

OVERDOSAGE: Paracetamol overdosage is due to a toxic single-dose or repeated large-dose ingestion (7.5 - 10 g daily for 1 - 2 days), or long-time ingestion. In acute Paracetamol overdosage, dose-dependent, potentially fatal hepatic necrosis is the most serious adverse effect.

Symptoms of Paracetamol overdosage include nausea, vomiting, colic, cyanosis on skin, mucosa, and nails.

Treatment: In the event of severe Paracetamol intoxication, full supportive measures should also be instituted. Gastric lavage should be carried out especially if the overdose was taken within the previous 4 hours.

The main detoxication therapy is use of sulfhydryl compound. N-acetylcysteine gives its effect followed by oral route or an intravenous infusion. N-acetylcysteine should be administered as soon as possible, preferably within 36 hours of overdosage. N-acetylcysteine is more effective if administered within 10 hours of overdosage. It can be diluted with water or alcohol-free drinks to a 5% solution and orally taken within 1 hour. Oral N-acetylcysteine is given as a 140 mg/kg body-weight initial dose followed by 70 mg/kg body-weight every four hours for 17 more doses.

Methionin, activated charcoal and/or salt cleaners are also advised to treat overdose.

DOSAGE & ADMINISTRATION: Dissolve the effervescent tablet in some fresh water until bubbling completely. The interval between oral doses should be over 4 hours and do not take more than 8 tablets daily.

Adults and children aged > 12 years orally take 1 tablet.

In case of severe pain, adults may be given 2 tablets.

* In case of patients with severe renal impairment (creatinine clearance < 10 ml/min.), the interval between oral doses should be at least 8 hours.

Or as directed by the physician.


* Maximum dose / 24 hours: the dosage should not exceed 4 g; the interval between oral doses should be over 4 hours.

* Prolonged administration by oneself should not be advised, consult a physician if:

- New symptoms occur.

- Fever gets worse (39.50C) and lasts for more than 3 days.

- Pain gets worse or lasts for more than 5 days.

Read the directions carefully before use.

Consult the physician for more information.

Shelf-life: 24 months from the manufacturing date.

Storage conditions: Store in dry places, not exceeding 300C.

Specifications: Manufacturer's.


There are yet no reviews for this product.